John Hohneker
CIK 1695378 · last filed 2026-07-09
John Hohneker is a corporate insider who has filed 23 SEC Form 4 insider transactions across 7 companies since 2017. The most recent filing, for CRIS, was dated Jul 9, 2026.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$0
7
23
$0
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| CRIS | Director | — | $4.83 | — | $0 | 7 | 2026-07-09 |
| AVBP | Director | — | $29.98 | — | $0 | 3 | 2026-06-22 |
| Carisma Therapeutics Inc. (CARM) Delisted | Director | — | $0.00 | — | $0 | 2 | 2024-06-27 |
| Evelo Biosciences, Inc. (EVLO) Delisted | Director | — | $0.00 | — | $0 | 3 | 2023-06-12 |
| Aravive, Inc. (ARAV) Delisted | Director | — | $0.04 | — | $0 | 3 | 2022-09-26 |
| HUMANIGEN, INC (HGEN) Delisted | Director | — | $0.00 | — | $0 | 3 | 2022-07-29 |
| Dimension Therapeutics, Inc. (DMTX) Delisted | Director | — | — | — | $0 | 2 | 2017-11-07 |
Recent Filings
23 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2026-07-09 | CRIS | Grant (A) | — | $0 | EDGAR |
| 2026-06-22 | AVBP | Grant (A) | — | $0 | EDGAR |
| 2025-06-20 | AVBP | Grant (A) | — | $0 | EDGAR |
| 2025-05-22 | CRIS | Grant (A) | — | $0 | EDGAR |
| 2025-01-30 | CRIS | Grant (A) | — | $0 | EDGAR |
| 2024-06-27 | Carisma Therapeutics Inc. (CARM) Delisted | Grant (A) | — | $0 | EDGAR |
| 2024-05-23 | CRIS | Grant (A) | — | $0 | EDGAR |
| 2024-05-20 | AVBP | Grant (A) | — | $0 | EDGAR |
| 2024-04-01 | Carisma Therapeutics Inc. (CARM) Delisted | Grant (A) | — | $0 | EDGAR |
| 2023-06-12 | Evelo Biosciences, Inc. (EVLO) Delisted | Grant (A) | — | $0 | EDGAR |
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.